Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$78,207,292
-$285,524,052 QoQ
Shares Held
259,799
-76.4% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#62
of 784 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ALNY ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in ALNY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,207,292 | 259,799 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $363,731,344 | 1,099,318 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $218,676,482 | 549,922 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $231,817,176 | 508,371 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $77,796,268 | 238,573 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $72,617,018 | 268,932 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $89,099,895 | 378,649 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $17,455,329 | 63,467 | Shares | Other | 2024-11-14 | |
| 2023-12-31 | $248,833 | 1,300 | Shares | Other | 2024-02-14 | |
| 2023-06-30 | $2,105,484 | 11,085 | Shares | Other | 2023-08-14 | |
| 2022-06-30 | $24,107,838 | 165,292 | Shares | Other | 2022-08-15 | |
| 2021-09-30 | $3,101,581 | 16,427 | Shares | Sole | 2021-11-15 | |
| 2020-06-30 | $8,624,593 | 58,231 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||